Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03135626
Other study ID # 2012/1728-1288
Secondary ID
Status Completed
Phase Phase 3
First received April 26, 2017
Last updated April 28, 2017
Start date March 15, 2013
Est. completion date February 15, 2016

Study information

Verified date April 2017
Source Istanbul University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This randomized clinical trial was conducted to examine and compare the effectiveness of pulpotomy in primary molars treated with calcium silicate based materials including Biodentine and two different mineral trioxide aggregate (MTA) products (white ProRoot® MTA and MTA Plus®). Ferric sulfate pulpotomy was selected to represent the control group. 116 primary molars in 29 children were treated by pulpotomy and followed for a period of 24 months.


Recruitment information / eligibility

Status Completed
Enrollment 38
Est. completion date February 15, 2016
Est. primary completion date January 15, 2014
Accepts healthy volunteers No
Gender All
Age group 5 Years to 7 Years
Eligibility Inclusion Criteria:

- Patients were eligible if they were 5 to 7 years old, healthy and cooperative, and had at least four carious primary molars, each of which was in a different quadrant and required a pulpotomy. The criteria for the selection of the teeth to be included in the study were presence of deep caries, presence of at least two-thirds of the root length radiographically and being restorable.

Exclusion Criteria:

- The exclusion criteria were the presence of any clinical or radiographic evidence of pulp degeneration (spontaneous or nocturnal tooth pain, tenderness to percussion, pathological mobility, internal or external root resorption, swelling or fistula, widened periodontal ligament (PDL) space, furcal or periapical radiolucency and teeth requiring more than 5 minutes to achieve hemostasis during clinical procedure. Teeth without permanent successor were not also included in the study.

Study Design


Related Conditions & MeSH terms

  • Extensive Decay in Primary Molars

Intervention

Drug:
Biodentine

ProRoot (Aggregate)

MTA Plus

Ferric Sulfate 20 % Dental Gel


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Istanbul University

Outcome

Type Measure Description Time frame Safety issue
Primary Total success rate Number of molars with both clinically and radiographically successful 6 months after pulpotomy treatment
Primary Total success rate Number of molars with both clinically and radiographically successful 12 months after pulpotomy treatment
Primary Total success rate Number of molars with both clinically and radiographically successful 24 months after pulpotomy treatment
See also
  Status Clinical Trial Phase
Completed NCT01733420 - Biodentine Versus White MTA Pulpotomy Phase 3